Viewpoint Molecular Targeting develops radiopharmaceutical therapeutics for cancer and complementary diagnostics for personalized medicine.

Therapeutics

Pharmaceutical

Health Care

Biotechnology

Viewpoint Molecular Targeting

Frances L. Johnson

Michael K. Schultz

Amos Hedt

Michael McDonald

The Research and Development team at Viewpoint Molecular Targeting focuses on innovating and refining radiopharmaceutical therapeutics for cancer treatment. This team conducts advanced research in peptide chemistry and diagnostics to personalize and improve the efficacy of cancer treatments.

Research and Development

Leadership Team

Business and Project Management

Research and Development

About

Team members

Other teams at Viewpoint Molecular Targeting

Leadership Team

Business and Project Management